XAIR - Beyond Air® Schedules Third Fiscal Quarter 2024 Financial Results Conference Call and Webcast | Benzinga
GARDEN CITY, N.Y., Jan. 18, 2024 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ:XAIR) ("Beyond Air" or the "Company"), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders and solid tumors (through its affiliate Beyond Cancer, Ltd. ("Beyond Cancer")), today announced that it will report financial results for its third fiscal quarter ended December 31, 2023 on Monday, February 12, 2024. The Company's management team is scheduled to host a conference call and webcast at 4:30 pm Eastern Time the same day.
| Conference Call & Webcast |
| Monday, February 12th @ 4:30 PM ET |
| Domestic: |
| 1-877-407-0784 |
| International: |
| 1-201-689-8560 |
Participants can use Guest dial-in #s above and be answered by an operator OR click the Call me™ link for instant telephone access to the event.
Call me™: https://callme.viavid.com/viavid/?callme=true&passcode=13738837&h=true&info=company-email&r=true&B=6
Webcast: https://viavid.webcasts.com/starthere.jsp?ei=1650835&tp_key=79566400ea
About Beyond Air®, Inc.
Beyond Air is a commercial stage medical device and biopharmaceutical company dedicated ...